About Conference
A premier global platform discussing cutting-edge vaccine development, immunological breakthroughs, and innovations in clinical trial design, safety, and efficacy.
Highlights
Covers novel vaccine platforms, immune response mechanisms, regulatory updates, and real-world clinical trial outcomes across infectious diseases, cancer, emerging global health threats and innovations in clinical trial design, safety, and efficacy.
Find on Map
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Combination Treatment May Improve Multiple Myeloma Outcomes
2.
Doctors Remain Trusted Sources for Cancer Info in Post-Pandemic Era
3.
Hospitalized Kate Middleton; Sen. Paul Demands That Fauci Go To Prison; COVID Returns to Class.
4.
Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC
5.
Significant Survival Boost With Novel ADCs in Relapsed Small-Cell Lung Cancer
1.
Deep Learning Fluorescence Imaging for Oral Cancer Surgery: In Silico Depth Quantification
2.
Preventing Childhood Platelet Functional Imbalance: A Comprehensive Clinical Review
3.
Quality of Life Using Precision Functional Recovery After Organ-Preserving Interventions
4.
The Science Behind Thrombolytic Drugs and Their Benefits
5.
Demystifying Hematoma Rectus Sheath: Knowing the Symptoms and Causes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
2.
Understanding the Role of Screening in Cancer Prevention
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
Recommended News For You
1.
Research finds COVID-19 mRNA vaccine sparks immune response to fight cancer
2.
Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?
3.
Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation
4.
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC
5.
Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven
Conferences That Might Interest You
Recommended Articles For You
1.
Surgical Innovation Using Hematopoietic Reserve Preservation During Major Surgery
2.
Programmable Cell Therapies for Selective Removal of Dysfunctional Hematopoietic Cell Populations
3.
Liquid Biopsy in SCLC: cfDNA Profiling for Diagnosis and Treatment Monitoring
4.
Gene Therapy for Hemophilia: A New Hope on the Horizon
5.
A Review of Cancer Treatment Evolution Towards Stem Cells and Gene Therapy
Boost Your Knowledge With These Quizzes
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge